NM_004855.5:c.-16A>G
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004855.5(PIGB):c.-16A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.203 in 1,597,260 control chromosomes in the GnomAD database, including 37,261 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4515 hom., cov: 32)
Exomes 𝑓: 0.20 ( 32746 hom. )
Consequence
PIGB
NM_004855.5 5_prime_UTR
NM_004855.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.339
Genes affected
PIGB (HGNC:8959): (phosphatidylinositol glycan anchor biosynthesis class B) This gene encodes a transmembrane protein that is located in the endoplasmic reticulum and is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene is thought to encode a member of a family of dolichol-phosphate-mannose (Dol-P-Man) dependent mannosyltransferases. [provided by RefSeq, Jul 2008]
PIGBOS1 (HGNC:50696): (PIGB opposite strand 1) Involved in regulation of endoplasmic reticulum unfolded protein response. Is integral component of mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]
RAB27A (HGNC:9766): (RAB27A, member RAS oncogene family) The protein encoded by this gene belongs to the small GTPase superfamily, Rab family. The protein is membrane-bound and may be involved in protein transport and small GTPase mediated signal transduction. Mutations in this gene are associated with Griscelli syndrome type 2. Alternative splicing occurs at this locus and four transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 15-55319235-A-G is Benign according to our data. Variant chr15-55319235-A-G is described in ClinVar as [Benign]. Clinvar id is 1327019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGB | NM_004855.5 | c.-16A>G | 5_prime_UTR_variant | Exon 1 of 12 | ENST00000164305.10 | NP_004846.4 | ||
PIGBOS1 | NM_001308421.2 | c.-447T>C | upstream_gene_variant | ENST00000436697.3 | NP_001295350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGB | ENST00000164305 | c.-16A>G | 5_prime_UTR_variant | Exon 1 of 12 | 1 | NM_004855.5 | ENSP00000164305.5 | |||
PIGBOS1 | ENST00000436697.3 | c.-447T>C | upstream_gene_variant | 2 | NM_001308421.2 | ENSP00000484893.1 | ||||
PIGB | ENST00000566999.5 | c.-16A>G | upstream_gene_variant | 3 | ENSP00000456531.1 |
Frequencies
GnomAD3 genomes AF: 0.230 AC: 34931AN: 152058Hom.: 4507 Cov.: 32
GnomAD3 genomes
AF:
AC:
34931
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.242 AC: 53676AN: 221532Hom.: 7876 AF XY: 0.237 AC XY: 28443AN XY: 120214
GnomAD3 exomes
AF:
AC:
53676
AN:
221532
Hom.:
AF XY:
AC XY:
28443
AN XY:
120214
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.201 AC: 289767AN: 1445084Hom.: 32746 Cov.: 32 AF XY: 0.201 AC XY: 144396AN XY: 717112
GnomAD4 exome
AF:
AC:
289767
AN:
1445084
Hom.:
Cov.:
32
AF XY:
AC XY:
144396
AN XY:
717112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.230 AC: 34960AN: 152176Hom.: 4515 Cov.: 32 AF XY: 0.233 AC XY: 17297AN XY: 74390
GnomAD4 genome
AF:
AC:
34960
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
17297
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1315
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Developmental and epileptic encephalopathy, 80 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at